Abstract
Background
It is common knowledge that esophageal achalasia patients have a high risk of developing esophageal carcinoma. The present study assessed the characteristics of esophageal carcinoma patients following laparoscopic Heller-Dor surgery (LHD) for esophageal achalasia.
Method
Among 622 cases which were esophageal achalasia patients and underwent LHD as the primary surgery, we compared the patient background, pathophysiology, symptoms, and surgical outcomes according to whether or not esophageal carcinoma occurred following surgery.
Results
Six cases (0.96%) of postoperative esophageal carcinoma were confirmed. The characteristics of the cases in which esophageal carcinoma occurred were older age, longer disease duration (p = 0.0362 and 0.0028, respectively), decreased sphincter pressure of the lower esophagus, a high rate of sigmoid esophagus, and a long esophagus lateral diameter (p = 0.0214, 0.001, and 0.0416, respectively). Moreover, no differences in surgical outcomes were confirmed and there were no differences in symptoms from before and following surgery.
Conclusion
The characteristics of esophageal carcinoma patients with achalasia following laparoscopic myotomy were an older age, longer disease duration, and greater progression of disease pathophysiology.
Similar content being viewed by others
References
Furuzawa-Carballeda J, Torres-Landa S, Valdovinos MA, Coss-Adame E, Martin Del Campo LA, Torres-Villalobos G (2016) New insights into the pathophysiology of achalasia and implications for future treatment. World J Gastroenterol 22:7892–7907
Schlottmann F, Patti MG (2018) Esophageal achalasia: current diagnosis and treatment. Expert Rev Gastroenterol Hepatol 12:711–721
Facciorusso A, Singh S, Abbas Fehmi SM, Annese V, Lipham J, Yadlapati R (2020) Comparative efficacy of first-line therapeutic interventions for achalasia: a systematic review and network meta-analysis. Surg Endosc. https://doi.org/10.1007/s00464-020-07920-x
Pandolfino JE, Gawron AJ (2015) Achalasia: a systematic review. JAMA 313:1841–1852
Tsuboi K, Omura N, Yano F, Hoshino M, Yamamoto SR, Akimoto S, Masuda T, Kashiwagi H, Yanaga K (2020) Therapeutic efficacy of laparoscopic Helle-Dor surgery for chest pain in patients with achalasia: a single institutional experience. Esophagus 2020(17):197–207
Japan esophageal society (2017) Descriptive Rules for Achalasia of the Esophagus, June 2012: 4th edition. Esophagus 14:275–289
Yadlapati R, Kahrilas PJ, Fox MR, Bredenoord AJ, Prakash Gyawali C, Roman S et al (2021) Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0. Neurogastroenterol Motil 33(1):e14058. https://doi.org/10.1111/nmo.14058
de Olivaira JM, Birgisson S, Doinoff C, Einstein D, Herts B, Davros W, Obuchowski N, Koehler RE, Richter J, Baker ME (1997) Timed barium swallow: a simple technique for evaluating esophageal emptying in patients with achalasia. AJR Am J Roentgenol 169:473–479
Reynolds JC, Parkman HP (1989) Achalasia. Gastroenterol Clin North Am 18:223–255
Spiess AE, Kahrilas PJ (1998) Treating achalasia: from whalebone to laparoscope. JAMA 280:638–642
Sandler RS, Nyren O, Ekbom A, Eisen GM, Yuen J, Josefsson S (1995) The risk of esophageal cancer in patients with achalasia. JAMA 274:1359–1362
Boeckxstaens GE, Zaninotto G, Richter JE (2014) Achalasia Lancet 383:83–93
Gillies CL, Farrukh A, Abrams KR, Mayberry JF (2019) Risk of esophageal cancer in achalasia cardia: a meta-analysis. JGH Open 3:196–200
Fagge CH (1872) A case of simple stenosis of the esophagus followed by epithelioma. Guys Hosp Rep 17:413–421
Ravi K, Geno DM, Katzka DA (2015) Esophageal cancer screening in achalasia: is there a consensus? Dis Esophagus 28:299–304
Gong EJ, Kim DH (2018) Retention esophagitis in patients with achalasia requires cancer surveillance. Clin Endosc 51:111–112
Loviscek LF, Cenoz MC, Badaloni AE, Agarinakazato O (1998) Early cancer in achalasia. Dis Esophagus 11:239–247
Nesteruk K, Spaander MCW, Leeuwenburgh I, Peppelenbosch MP, Fuhler GM (2019) Achalasia and associated esophageal cancer risk: what lessons can we learn from the molecular analysis if Barrett’s-associated adenocarcinoma? Biochim Biophys Acta Rev Cancer 1872:188291. https://doi.org/10.1016/j.bbcan.2019.04.007
Tustumi F, Bernardo WM, da Rocha JRM, Szachnowicz S, Seguro FC, Bianchi ET, Sallum RAA, Cecconello I (2017) Esophageal achalasia: a risk factor for carcinoma. A systematic review and meta-analysis. Dis Esophagus 30:1–8
Fujii T, Yamana H, Sueyoshi S, Fujita H, Tanaka Y, Kubota M, Toh U, Mine T, Sasahara H, Shirouzu K, Kato S, Morimatsu M (2000) Histopathological analysus of non-malignant and malignant epithelium in achalasia of the esophagus. Dis Esophagus 13:110–116
Leeuwenburgh I, Gerrits MM, Capello A, van den Bogert B, van Dekken H, Steyerberg EW, Siersema PD, Kuipers EJ (2010) Expression of p53 as predictor for the development of esophageal cancer in achalasia patients. Dis Esophagus 23:506–511
Zaninotto G, Rizzetto C, Zambon P, Guzzinati S, Finotti E, Costantini M (2008) Long-term outcome and risk of oesophageal cancer after surgery for achalasia. Br J Surg 95:1488–1494
Sato H, Yokomichi H, Takahashi K, Tominaga K, Mizusawa T, Kimura N, Kawata Y, Terai S (2019) Epidemiological analysis of achalasia in Japan using a large-scale claims database. J Gastroenterol 54:621–627
Markar SR, Wiggins T, MacKenzie H, Faiz O, Zaninotto G, Hanna GB (2019) Incidence and risk factors for esophageal cancer following achalasia treatment: national population-based case-control study. Dis Esophagus 32:1–7
Leeuwenburgh I, Scholten P, Alderliesten J, Tilanus HW, Looman CWN, Steijerberg EW, Kuipers EJ (2010) Long-term esophageal cancer risk in patients with primary achalasia: a prospective study. Am J Gastroenterol 105:2144–2149
Brucher BL, Stein HJ, Bartels H, Feussner H, Siewert JR (2001) Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg 25:745–749
Zagari RM, Marasco G, Tassi V, Ferretti S, Lugaresi M, Fortunato F, Bazzoli F, Mattioli S (2021) Risk of squamous cell carcinoma and adenocarcinoma of the esophagus in patients with achalasia: a long-term prospective cohort study in Italy. Am J Gastorneterol 116:289–295
Vaezi MF, Pandlfino JE, Vela MF (2013) ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol 108:1238–1249
Fukushima N, Masuda T, Yano F, Omura N, Tsuboi K, Hoshino M, Yamamoto SR, Akimoto S, Sakashita Y, Mitsumori N, Kashiwagi H, Ikegami T (2020) Over ten-year outcomes of laparoscopic Heller-myotomy with Dor-fundoplication with achalasia: single-center experience with annual endoscopic surveillance. Surg Endosc. https://doi.org/10.1007/s00464-020-08148-5
Author information
Authors and Affiliations
Contributions
Study conception and design-Tsuboi, Omura, Yano. Acquisition of data-Tsuboi, Omura, Yano, Hoshino, Yamamoto, Akimoto, Masuda, Sakashita, Fukushima, Kashiwagi. Analysis and interpretation of data-Tsuboi, Omura, Yano. Drafting of manuscript-Tsuboi, Omura. Critical revision of manuscript-Tsuboi, Omura.
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tsuboi, K., Omura, N., Yano, F. et al. The patient characteristics of esophageal carcinoma following laparoscopic myotomy for esophageal achalasia. Langenbecks Arch Surg 406, 2679–2686 (2021). https://doi.org/10.1007/s00423-021-02270-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-021-02270-1